Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006

Kimberly E. Stepien, Alexander M. Eaton, Glenn J. Jaffe, Janet L. Davis, Junaid Raja, William Feuer

Research output: Contribution to journalArticle

32 Scopus citations

Abstract

PURPOSE: To compare the incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide injections during a 6 month period in 2006 to the same period in 2005 and determine the incidence after switching to intravitreal preservative-free triamcinolone acetonide. METHODS: Retrospective multicenter interventional case series in which patients receiving intravitreal triamcinolone acetonide at three institutions from March 2005 to August 2005 and from March 2006 to August 2006 and intravitreal preservative-free triamcinolone acetonide from late summer 2006 through February 2007 were reviewed for the development of sterile endophthalmitis. RESULTS: From March 2005 to August 2005, the rate of sterile endophthalmitis was 0% at all institutions. From March 2006 to August 2006, a statistically significant increase in sterile endophthalmitis was seen at all institutions with frequencies of 3.5% to 6.3% (P < 0.001). With transition to preservative-free triamcinolone acetonide, sterile endophthalmitis over the next 6 months decreased to 0% at two sites and to 2.5% (from 5.5%) at the third institution (P < 0.009). CONCLUSIONS: A statistically significant increase in the rate of sterile endophthalmitis after intravitreal triamcinolone acetonide was seen in a 6 month period in 2006 when compared with the same period in 2005. Transition to preservative-free triamcinolone acetonide produced a frequency of sterile endophthalmitis similar to 2005.

Original languageEnglish (US)
Pages (from-to)207-213
Number of pages7
JournalRetina
Volume29
Issue number2
DOIs
StatePublished - Feb 1 2009

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006'. Together they form a unique fingerprint.

  • Cite this